101 related articles for article (PubMed ID: 9262518)
1. Skeletal casein kinase activity defect in the HYP mouse.
Rifas L; Cheng S; Halstead LR; Gupta A; Hruska KA; Avioli LV
Calcif Tissue Int; 1997 Sep; 61(3):256-9. PubMed ID: 9262518
[TBL] [Abstract][Full Text] [Related]
2. X-linked hypophosphatemic rickets and the murine Hyp homologue.
Hruska KA; Rifas L; Cheng SL; Gupta A; Halstead L; Avioli L
Am J Physiol; 1995 Mar; 268(3 Pt 2):F357-62. PubMed ID: 7900834
[TBL] [Abstract][Full Text] [Related]
3. Protein kinases of cultured osteoblasts: selectivity for the extracellular matrix proteins of bone and their catalytic competence for osteopontin.
Salih E; Ashkar S; Gerstenfeld LC; Glimcher MJ
J Bone Miner Res; 1996 Oct; 11(10):1461-73. PubMed ID: 8889846
[TBL] [Abstract][Full Text] [Related]
4. Contributions of increased osteopontin and hypophosphatemia to dentoalveolar defects in osteomalacic Hyp mice.
Mohamed FF; Hoac B; Phanrungsuwan A; Tan MH; Giovani PA; Ghiba S; Murshed M; Foster BL; McKee MD
Bone; 2023 Nov; 176():116886. PubMed ID: 37634682
[TBL] [Abstract][Full Text] [Related]
5. Phosphate transport in osteoblasts from normal and X-linked hypophosphatemic mice.
Rifas L; Dawson LL; Halstead LR; Roberts M; Avioli LV
Calcif Tissue Int; 1994 Jun; 54(6):505-10. PubMed ID: 8082056
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia.
Barros NM; Hoac B; Neves RL; Addison WN; Assis DM; Murshed M; Carmona AK; McKee MD
J Bone Miner Res; 2013 Mar; 28(3):688-99. PubMed ID: 22991293
[TBL] [Abstract][Full Text] [Related]
7. Genetic Ablation of Osteopontin in Osteomalacic Hyp Mice Partially Rescues the Deficient Mineralization Without Correcting Hypophosphatemia.
Hoac B; Østergaard M; Wittig NK; Boukpessi T; Buss DJ; Chaussain C; Birkedal H; Murshed M; McKee MD
J Bone Miner Res; 2020 Oct; 35(10):2032-2048. PubMed ID: 32501585
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.
Yuan B; Takaiwa M; Clemens TL; Feng JQ; Kumar R; Rowe PS; Xie Y; Drezner MK
J Clin Invest; 2008 Feb; 118(2):722-34. PubMed ID: 18172553
[TBL] [Abstract][Full Text] [Related]
9. Altered osteoblast gluconeogenesis in X-linked hypophosphatemic mice is associated with a depressed intracellular pH.
Rifas L; Gupta A; Hruska KA; Avioli LV
Calcif Tissue Int; 1995 Jul; 57(1):60-3. PubMed ID: 7671167
[TBL] [Abstract][Full Text] [Related]
10. Microsomal casein kinase II in endoplasmic reticulum- and Golgi apparatus-rich fractions of ROS 17/2.8 osteoblast-like cells: an enzyme that modifies osteopontin.
Wu CB; Pan YM; Simizu Y
Calcif Tissue Int; 1995 Oct; 57(4):285-92. PubMed ID: 8673866
[TBL] [Abstract][Full Text] [Related]
11. Identification of the phosphorylated sites of metabolically 32P-labeled osteopontin from cultured chicken osteoblasts.
Salih E; Ashkar S; Gerstenfeld LC; Glimcher MJ
J Biol Chem; 1997 May; 272(21):13966-73. PubMed ID: 9153260
[TBL] [Abstract][Full Text] [Related]
12. Direct demonstration of a humorally-mediated inhibition of renal phosphate transport in the Hyp mouse.
Lajeunesse D; Meyer RA; Hamel L
Kidney Int; 1996 Nov; 50(5):1531-8. PubMed ID: 8914019
[TBL] [Abstract][Full Text] [Related]
13. Characterization and partial purification of microsomal casein kinase II from osteoblast-like cells: an enzyme that phosphorylates osteopontin and phosphophoryn.
Wu CB; Shimizu Y; Ng A; Pan YM
Connect Tissue Res; 1996; 34(1):23-32. PubMed ID: 8835845
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase activity and protein kinase inhibitor in mouse kidney: effect of the X-linked Hyp mutation and vitamin D status.
Tenenhouse HS; Henry HL
Endocrinology; 1985 Nov; 117(5):1719-26. PubMed ID: 2994997
[TBL] [Abstract][Full Text] [Related]
15. Partial rescue of the Hyp phenotype by osteoblast-targeted PHEX (phosphate-regulating gene with homologies to endopeptidases on the X chromosome) expression.
Bai X; Miao D; Panda D; Grady S; McKee MD; Goltzman D; Karaplis AC
Mol Endocrinol; 2002 Dec; 16(12):2913-25. PubMed ID: 12456809
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic mineralization defect in Hyp mouse osteoblasts.
Xiao ZS; Crenshaw M; Guo R; Nesbitt T; Drezner MK; Quarles LD
Am J Physiol; 1998 Oct; 275(4):E700-8. PubMed ID: 9755091
[TBL] [Abstract][Full Text] [Related]
17. Hyper-expression of osteocalcin mRNA in odontoblasts of Hyp mice.
Onishi T; Ogawa T; Hayashibara T; Hoshino T; Okawa R; Ooshima T
J Dent Res; 2005 Jan; 84(1):84-8. PubMed ID: 15615882
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific mineralization defects in the periodontium of the Hyp mouse model of X-linked hypophosphatemia.
Coyac BR; Falgayrac G; Baroukh B; Slimani L; Sadoine J; Penel G; Biosse-Duplan M; Schinke T; Linglart A; McKee MD; Chaussain C; Bardet C
Bone; 2017 Oct; 103():334-346. PubMed ID: 28764922
[TBL] [Abstract][Full Text] [Related]
19. Protein kinases of cultured chicken osteoblasts that phosphorylate extracellular bone proteins.
Salih E; Ashkar S; Zhou HY; Gerstenfeld L; Glimcher MJ
Connect Tissue Res; 1996; 35(1-4):207-13. PubMed ID: 9084659
[TBL] [Abstract][Full Text] [Related]
20. Expression and distribution of SIBLING proteins in the predentin/dentin and mandible of hyp mice.
Zhang B; Sun Y; Chen L; Guan C; Guo L; Qin C
Oral Dis; 2010 Jul; 16(5):453-64. PubMed ID: 20233318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
